These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31729099)

  • 1. Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians.
    Dekanek EW; Thull DL; Massart M; Grubs RE; Rajkovic A; Mai PL
    J Genet Couns; 2020 Feb; 29(1):122-130. PubMed ID: 31729099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a scale for assessing attitudes towards outcomes of genetic cancer testing among primary care providers and breast specialists.
    Bouhnik AD; N'Diaye K; Evans DG; Harris H; Tibben A; van Asperen C; Schmidtke J; Nippert I; Mancini J; Julian-Reynier C
    PLoS One; 2017; 12(6):e0178447. PubMed ID: 28570656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition.
    Escher M; Sappino AP
    Ann Oncol; 2000 Sep; 11(9):1131-5. PubMed ID: 11061607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.
    Hall J; Gray S; A'Hern R; Shanley S; Watson M; Kash K; Croyle R; Eeles R
    Fam Cancer; 2009; 8(1):5-13. PubMed ID: 18679829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1/2 genetic testing in the community setting.
    Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
    J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest in BRCA1/2 testing in a primary care population.
    Armstrong K; Weber B; Ubel PA; Guerra C; Schwartz JS
    Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.
    Linfield DT; Rothberg MB; Pfoh ER; Noss R; Cassard L; Powers JC; Lipold L; Martinez KA
    Breast Cancer Res Treat; 2022 Sep; 195(2):153-160. PubMed ID: 35842521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing Clinical Follow-Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing.
    Chadwell SE; He H; Knapke S; Lewis J; Sisson R; Hopper J
    J Genet Couns; 2018 Sep; 27(5):1210-1219. PubMed ID: 29550970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
    Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
    Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
    Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
    Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
    Bellcross CA; Kolor K; Goddard KA; Coates RJ; Reyes M; Khoury MJ
    Am J Prev Med; 2011 Jan; 40(1):61-6. PubMed ID: 21146769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.